Effect of ovariectomy and sex hormone replacement on glutathione and glutathione- related enzymes in rat hepatocarcinogenesis

Pathology

Volumn 27, Issue 1, 1995, Pages 30-35

  Hambali, Zarida ^a   Ngah, Wan Z W ^a   Wahid, Shahrom A ^a   Kadir, Khalid A ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Estrogen; Glutathione; Glutathione peroxidase; Glutathione reductase; Glutathione S Transferase; Hepatocarcinogenesis; Ovariectomy; Progesterone

Indexed keywords

DIETHYLNITROSAMINE; ESTROGEN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; N (2 FLUORENYL)ACETAMIDE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; LIVER CARCINOGENESIS; NONHUMAN; OVARIECTOMY; RAT;

2-ACETYLAMINOFLUORENE; ADENOMA, LIVER CELL; ANIMAL; DIETHYLNITROSAMINE; ESTRADIOL; FEMALE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; OVARIECTOMY; PROGESTERONE; RATS; RETICULIN; SUPPORT, NON-U.S. GOV'T;

EID: 0029022656     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313029500169422     Document Type: Article

References (37)

1. Wilkinson ML, Sex steroids and primary hepatocellular carcinoma. Anticancer Res 1987; 7(5B): 1071-7.
2. Yager JD, Zurlo J, Ni N. Sex hormones and tumor promotion in liver. Proc Soc Exp Biol Med 1991; 198(2): 667-74.
3. Neuberger J, Forman D, Doll R et al. Oral contraceptive and hepatocellular carcinoma. Br Med J 1986; 292: 1355-7.
4. Nagasue N, Kohno H. Hepatocellular carcinoma and sex hormones. HPB Surgery 1992; 6: 1-6.
5. Yager JD, Yager R. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats. Cancer Res 1980; 40: 3680-5.
6. Yager JD, Campbell HA, Longnecker DS et al. Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol and not estradiol. Cancer Res 1984; 44(9): 3862-69.
7. Taper H, de Gerlache J, Lans M et al. Estrogens and primary liver tumors. In: Wolff JP, Scott JP, eds. Hormones and sexual factors in human cancer aetiology. Elsevier Sci Pub BV 1984: 163-74.
8. Edmonson HA, Reynolds TB, Henderson B et al. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 1977; 86(2): 180-82.
9. Erdstein J, Wisebord S, Mishkin SY et al. The effect of several sex hormones on the growth rate of three Morris hepatoma tumor lines. Hepatology 1989; 9(4): 621-4.
10. Lui WY, P’Eng FK, Liu TY et al. Hormonal therapy for hepatocellular carcinoma. Medical Hypotheses 1991; 36: 162-5.
11. Campen DB, Sloop TC, Maronpot RR et al. Continued development of hepatic gamma-glutamyltranspeptidase-positive foci upon withdrawal of 17 alpha-ethynylestradiol in diethylnitrosamine- initiated rats. Cancer Res 1987; 47(9): 2328-33.
12. Roy D, Liehr JG. Changes in activities of free radical detoxifying enzymes in kidneys of male Syrian hamsters treated with estradiol. Cancer Res 1989; 49: 1475-80.
13. Roomi MW, Ho RK, Sharma DSR et al. A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models of rat. Cancer Res 1985; 45: 564-71.
14. Bose S, Guna S, Paul P et al. The role of glutathione in evaluating the efficacy of antimetabolites in transplanted tumors. Neoplasma 1991; 38(2): 193-8.
15. Hendrich S, Pitot HC. Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis. Cancer Metastasis Rev 1987; 6: 155-78.
16. Kitahara A, Yamazaki T, Ishikawa T et al. Changes in activities of glutathione peroxidase and glutathione reductase during chemical hepatocarcinogenesis in the rat. Gann 1983; 74: 649-55.
17. Legan SJ, Allyn Coon G, Karsch FJ. Role of estrogen as initiator of daily LH surges in the ovariectomized rat. Endocrinology 1975; 96(1): 50-6.
18. Taper HS. The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-Nitrosomorpholine induced liver carcinogenesis in ovariectomized female rats. Cancer 1987; 42: 462-67.
19. Solt D, Faber E. New principle for the analysis of chemical carcinogenesis. Nature 1976; 263: 701-3.
20. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-7.
21. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferase; the first enzymatic step in the mercapturic acid formation. J Biol Chem 1974; 249: 7130-39.
22. Racker E. Glutathione reductase (liver and yeast). Methods in Enzymol 1955; 2: 722-25.
23. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976; 71: 952-58.
24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein- dye binding. Anal Biochem 1976; 72: 248-54.
25. Gordon H, Sweets HH. A simple method for the silver impregnation of reticulum. Am J Pathology 1936; 12: 545.
26. Squire RA, Levitt MH. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res 1975; 35: 3214-23.
27. Igarashi T, Satoh T, Ono S et al. Effect of steroidal sex hormones on the sex-related differences in the hepatic activities of gamma- glutamyltranspeptidase, glutathione S-transferase and glutathione peroxidase in rats. Res Comm Chem Patho Pharm 1984; 45: 225-32.
28. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutation Research 1988; 202: 343-61.
29. Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 1992; 27: 337-84.
30. Goldfarb S, Pugh TD. Multistage rodent hepatocarcinogenesis. Prog Liver Dis 1986; 8: 597-620.
31. Hendrich S, Leveston AO, Pitot HC. Ovariectomy promotes the growth of altered hepatic foci after withdrawal and reintroduction of phenobarbital during hepatocarcinogenesis in rats. Eur J Cancer Prev 1992; 1: 407-14.
32. Katayama S, Ohmori T, Maeura Y et al. Early stages of N-2-FAA induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development. J Natl Cancer Inst 1984; 73: 141-49.
33. Wanless IR, Medline A. Role of estrogens as promoters of hepatic neoplasia. Lab Invest 1982; 46: 313-20.
34. Sumi C, Yokoro K, Kajitani T et al. A Synergism of diethylstil- besterol and other carcinogens in concurrent development of hepatic, mammary, and pituitary tumors in castrated male rats. J Natl Cancer Inst 1980; 70: 169-75.
35. Sumi C, Yokoro K, Matsushima R. Induction of hepatic tumors by diethylstilbestrol alone or in synergism with N-nitrosobutylurea in castrated male WF rats. J Natl Cancer Inst 1983; 937-42.
36. Higashi S, Tomito T, Mizumoto R et al. Development of hepatoma in rats following oral administration of synthetic estrogen and progestogen. Gann 1980; 71: 576-77.
37. Asmah R, Wan Zurinah WN, Nor Aripin S et al. Long-term administration of tocotrienols and tumor-marker enzyme activities during hepatocarcinogenesis in rats. Nutrition 1993; 9(3): 229-32.